Q

Qingdao Baheal Medical Inc
SZSE:301015

Watchlist Manager
Qingdao Baheal Medical Inc
SZSE:301015
Watchlist
Price: 27.18 CNY -1.52%
Market Cap: 14.3B CNY
Have any thoughts about
Qingdao Baheal Medical Inc?
Write Note

Net Margin
Qingdao Baheal Medical Inc

9.6%
Current
7%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
9.6%
=
Net Income
722.5m
/
Revenue
7.5B

Net Margin Across Competitors

Country CN
Market Cap 14.3B CNY
Net Margin
10%
Country US
Market Cap 77.7B USD
Net Margin
1%
Country US
Market Cap 48.6B USD
Net Margin
1%
Country US
Market Cap 48.4B USD
Net Margin
1%
Country US
Market Cap 30.3B USD
Net Margin
1%
Country US
Market Cap 9.3B USD
Net Margin
3%
Country CN
Market Cap 65.2B CNY
Net Margin
8%
Country KR
Market Cap 12.2T KRW
Net Margin
7%
Country CN
Market Cap 64.3B HKD
Net Margin
1%
Country CN
Market Cap 60.5B CNY
Net Margin
1%
Country IT
Market Cap 5.5B EUR
Net Margin
7%
No Stocks Found

Qingdao Baheal Medical Inc
Glance View

Market Cap
14.3B CNY
Industry
Health Care

Qingdao Baheal Medical, Inc. engages in the provision of marketing services for pharmaceutical product manufacturers. The company is headquartered in Qingdao, Shandong and currently employs 2,396 full-time employees. The company went IPO on 2021-06-30. The firm provides brand operation, wholesale distribution and retail services for pharmaceutical products. Its brand operation services include consumer education, product academic promotion, marketing planning, business contacts, product distribution, flow tracking and supply chain management services. The firm's wholesale distribution business mainly centers on Qingdao and Beijing, and radiates second-level and above hospitals, community clinics and pharmacies in surrounding cities. Its wholesale distribution products include medicines, Chinese herbal medicine pieces, medical equipment, diagnostic reagents, medical consumables, among others. The firm mainly conducts its business within domestic market.

Intrinsic Value
45.79 CNY
Undervaluation 41%
Intrinsic Value
Price
Q

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
9.6%
=
Net Income
722.5m
/
Revenue
7.5B
What is the Net Margin of Qingdao Baheal Medical Inc?

Based on Qingdao Baheal Medical Inc's most recent financial statements, the company has Net Margin of 9.6%.